These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10343322)

  • 41. New techniques to detect oxidative stress markers: mass spectrometry-based methods to detect isoprostanes as the gold standard for oxidative stress in vivo.
    Yin H
    Biofactors; 2008; 34(2):109-24. PubMed ID: 19706977
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The isoprostanes: unique bioactive products of lipid peroxidation. An overview.
    Liu TZ; Stern A; Morrow JD
    J Biomed Sci; 1998; 5(6):415-20. PubMed ID: 9845844
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantification of F2-isoprostanes by gas chromatography/mass spectrometry as a measure of oxidant stress.
    Musiek ES; Morrow JD
    Curr Protoc Toxicol; 2005 Jun; Chapter 17():Unit 17.6. PubMed ID: 23045115
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipid peroxidation in mice fed a choline-deficient diet as evaluated by total hydroxyoctadecadienoic acid.
    Yoshida Y; Itoh N; Hayakawa M; Habuchi Y; Inoue R; Chen ZH; Cao J; Cynshi O; Niki E
    Nutrition; 2006 Mar; 22(3):303-11. PubMed ID: 16500556
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The isoprostanes--25 years later.
    Milne GL; Dai Q; Roberts LJ
    Biochim Biophys Acta; 2015 Apr; 1851(4):433-45. PubMed ID: 25449649
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Isoprostanes and oxidative stress in brain damage in newborns].
    Minghetti L; Bernardo A; Greco A
    Ann Ist Super Sanita; 2001; 37(4):537-43. PubMed ID: 12046223
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antioxidants significantly affect the formation of different classes of isoprostanes and neuroprostanes in rat cerebral synaptosomes.
    Montine TJ; Montine KS; Reich EE; Terry ES; Porter NA; Morrow JD
    Biochem Pharmacol; 2003 Feb; 65(4):611-7. PubMed ID: 12566089
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts.
    Roberts LJ; Salomon RG; Morrow JD; Brame CJ
    FASEB J; 1999 Jul; 13(10):1157-68. PubMed ID: 10385607
    [TBL] [Abstract][Full Text] [Related]  

  • 49. F3-Isoprostanes as a Measure of in vivo Oxidative Damage in Caenorhabditis elegans.
    Nguyen TT; Aschner M
    Curr Protoc Toxicol; 2014 Nov; 62():11.17.1-13. PubMed ID: 25378241
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans.
    Morrow JD
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):279-86. PubMed ID: 15591226
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nonenzymatic free radical-catalyzed generation of thromboxane-like compounds (isothromboxanes) in vivo.
    Morrow JD; Awad JA; Wu A; Zackert WE; Daniel VC; Roberts LJ
    J Biol Chem; 1996 Sep; 271(38):23185-90. PubMed ID: 8798513
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease.
    Morrow JD; Roberts LJ
    Am J Respir Crit Care Med; 2002 Dec; 166(12 Pt 2):S25-30. PubMed ID: 12471085
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isoprostanes: novel bioactive products of lipid peroxidation.
    Basu S
    Free Radic Res; 2004 Feb; 38(2):105-22. PubMed ID: 15104204
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regiochemistry of neuroprostanes generated from the peroxidation of docosahexaenoic acid in vitro and in vivo.
    Yin H; Musiek ES; Gao L; Porter NA; Morrow JD
    J Biol Chem; 2005 Jul; 280(28):26600-11. PubMed ID: 15894799
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isoprostanes.
    Roberts LJ; Milne GL
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S219-23. PubMed ID: 18957694
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors regulating isoprostane formation in vivo.
    Basu S; Helmersson J
    Antioxid Redox Signal; 2005; 7(1-2):221-35. PubMed ID: 15650410
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isoprostanes and related compounds: update 2006.
    Milne GL; Morrow JD
    Antioxid Redox Signal; 2006; 8(7-8):1379-84. PubMed ID: 16910785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of oxidative stress markers and prostaglandins after chronic training of triathletes.
    Medina S; Domínguez-Perles R; Cejuela-Anta R; Villaño D; Martínez-Sanz JM; Gil P; García-Viguera C; Ferreres F; Gil JI; Gil-Izquierdo A
    Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):79-86. PubMed ID: 22824210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Are isoprostanes a clinical marker for antioxidant drug investigation?
    Souvignet C; Cracowski JL; Stanke-Labesque F; Bessard G
    Fundam Clin Pharmacol; 2000; 14(1):1-10. PubMed ID: 10681068
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclopentenone eicosanoids as mediators of neurodegeneration: a pathogenic mechanism of oxidative stress-mediated and cyclooxygenase-mediated neurotoxicity.
    Musiek ES; Milne GL; McLaughlin B; Morrow JD
    Brain Pathol; 2005 Apr; 15(2):149-58. PubMed ID: 15912888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.